Company: NDRA
Filing Date: 2025-10-30
Form Type: 424B5
Source: 0001213900-25-103705
Chunk: 68

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-30
Form: 424B5
Chunk 68
---
 prohibits a Delaware corporation from
engaging in any business combination (as defined below) with any interested stockholder (as defined below) for a period of three years
following the date that the stockholder became an interested stockholder, unless:

| ● | prior to that date, the board of directors of the corporation approved either the business combination or the transaction that resulted 
 in the stockholder becoming an interested stockholder;                                                                                  |

| ● | upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder       
 owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of     
 determining the number of shares of voting stock outstanding (but not the voting stock owned by the interested stockholder) those shares   
 owned by persons who are directors and officers and by excluding employee stock plans in which employee participants do not have the right 
 to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or                     |

| ● | on or subsequent to the time the business combination is approved by the board of directors of the corporation and authorized at an   
 annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding 
 voting stock that is not owned by the interested stockholder.                                                                         |

In general, Section 203 defines “business
combination” to include the following:

| ● | any merger or consolidation involving the corporation and the interested stockholder; |

| ● | any sale, lease, exchange, mortgage, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving 
 the interested stockholder;                                                                                                          |

| ● | subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation 
 to the interested stockholder;                                                                                                             |

| ● | subject to limited exceptions, any transaction involving the corporation that has the effect of increasing the proportionate share 
 of the stock of any class or series of the corporation beneficially owned by the interested stockholder; or                        |

| ● | the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided 
 by or through the corporation.                                                                                                            |

<div align='center'>21</div>

Section 203 generally defines an interested stockholder
as any entity or person beneficially owning 15% or